Your browser doesn't support javascript.
loading
Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response.
Ou, Xiang; Gao, Jia-Hui; He, Lin-Hao; Yu, Xiao-Hua; Wang, Gang; Zou, Jin; Zhao, Zhen-Wang; Zhang, Da-Wei; Zhou, Zhi-Jiao; Tang, Chao-Ke.
Afiliación
  • Ou X; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Medical Research Experiment Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China; Department of Endocrinology, Th
  • Gao JH; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Medical Research Experiment Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China.
  • He LH; School of Pharmacy and Life Science College, Medical Research Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China.
  • Yu XH; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Medical Research Experiment Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China.
  • Wang G; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Medical Research Experiment Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China.
  • Zou J; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Medical Research Experiment Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China.
  • Zhao ZW; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Medical Research Experiment Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China.
  • Zhang DW; Department of Pediatrics and Group on the Molecular and Cell Biology of Lipids, University of Alberta, Edmonton, Alberta T6G 2S2, Canada.
  • Zhou ZJ; Department of Pathology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic address: zjzhou5790@163.com.
  • Tang CK; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Medical Research Experiment Center, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China. Electronic address: tangchaoke@
Article en En | MEDLINE | ID: mdl-31678621

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Colesterol / Angiopoyetina 1 / Aterosclerosis / Inflamación Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Biochim Biophys Acta Mol Cell Biol Lipids Año: 2020 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Colesterol / Angiopoyetina 1 / Aterosclerosis / Inflamación Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Biochim Biophys Acta Mol Cell Biol Lipids Año: 2020 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Países Bajos